High Prevalence of Erythromycin- and Tetracycline-Resistant Clinical Isolates of Streptococcus pneumoniae in Iran
暂无分享,去创建一个
[1] P. Brzoska,et al. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona , 2012, BMC Microbiology.
[2] K. Ko,et al. Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study , 2012, Antimicrobial Agents and Chemotherapy.
[3] E. Leitner,et al. Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria, 1997-2008. , 2010, International journal of antimicrobial agents.
[4] M. Bokaeian,et al. Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan , 2010, Iranian Red Crescent medical journal.
[5] F. Weber,et al. Antimicrobial susceptibility of Streptococcus pneumoniae and genotypic characterization of erythromycin-resistant strains in porto alegre, Brazil , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[6] F. Kong,et al. Distribution of Serotypes, Genotypes, and Resistance Determinants among Macrolide-Resistant Streptococcus pneumoniae Isolates , 2010, Antimicrobial Agents and Chemotherapy.
[7] J. Kohanteb,et al. Penicillin-Resistant Streptococcus pneumoniae in Iran , 2006, Medical Principles and Practice.
[8] J. Liñares,et al. Increase of the M Phenotype among Erythromycin-Resistant Streptococcus pneumoniae Isolates from Spain Related to the Serotype 14 Variant of the Spain9V-3 Clone , 2006, Antimicrobial Agents and Chemotherapy.
[9] H. Goossens,et al. Multiplex PCR for Simultaneous Detection of Macrolide and Tetracycline Resistance Determinants in Streptococci , 2005, Antimicrobial Agents and Chemotherapy.
[10] K. Ko,et al. High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study) , 2004, Antimicrobial Agents and Chemotherapy.
[11] G. Syrogiannopoulos,et al. Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A) , 2003, Antimicrobial Agents and Chemotherapy.
[12] M. P. Montanari,et al. Phenotypic and Molecular Characterization of Tetracycline- and Erythromycin-Resistant Strains of Streptococcus pneumoniae , 2003, Antimicrobial Agents and Chemotherapy.
[13] E. Bingen,et al. Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France , 2001, Antimicrobial Agents and Chemotherapy.
[14] P. Angot,et al. Macrolide Resistance Phenotypes and Genotypes in French Clinical Isolates of Streptococcus pneumoniae , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[15] C. Pai,et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Feyzabadi,et al. DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN , 2003 .
[17] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .